Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites.

Author: GriffinPatricia M, JonesTimothy F, NelsonJennifer M, ScallanElaine, SmithKirk E

Paper Details 
Original Abstract of the Article :
Antimicrobial and antimotility agents are not recommended for the treatment of Shiga toxin-producing Escherichia coli O157 infection. In our study, many persons with Shiga toxin-producing E. coli O157 infection took antimicrobial (62%) and antimotility agents (32%); 43 (29%) of 146 reported commenci...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1093/cid/cir087

データ提供:米国国立医学図書館(NLM)

Navigating the Desert of Shiga Toxin-Producing Escherichia coli O157: A Reminder for Patients

The microbial world is a complex and dynamic ecosystem, with many potential threats to human health. This study delves into the world of Shiga toxin-producing *Escherichia coli* O157 (*E. coli* O157), a dangerous bacteria that can cause severe gastrointestinal illness. The study highlights the importance of following medical guidelines for managing *E. coli* O157 infection, emphasizing the potential risks associated with unnecessary antimicrobial and antimotility agents.

The Desert of *E. coli* O157: Avoiding Unnecessary Detours

The study emphasizes the importance of adhering to medical guidelines for managing *E. coli* O157 infection. It’s like navigating a desert with a compass and a map – following the recommended route is crucial for avoiding unnecessary detours and potential complications. The research underscores the potential risks associated with using antimicrobial and antimotility agents, particularly in cases of *E. coli* O157 infection.

Staying Safe in the Desert of *E. coli* O157: A Reminder for Patients

This study serves as a reminder for patients to be proactive in managing their health, particularly when dealing with potentially dangerous infections. Following medical guidelines, seeking prompt medical attention, and avoiding unnecessary medication use are crucial steps in navigating the desert of *E. coli* O157 infection.

Dr.Camel's Conclusion

This study highlights the importance of following medical guidelines for managing *E. coli* O157 infection. It’s like navigating a desert with a compass and a map – a well-defined route can help avoid unnecessary detours and potential complications. The research underscores the importance of seeking professional medical advice and adhering to recommended treatment protocols to ensure optimal outcomes for patients.

Date :
  1. Date Completed 2011-08-15
  2. Date Revised 2015-11-19
Further Info :

Pubmed ID

21467017

DOI: Digital Object Identifier

10.1093/cid/cir087

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.